|
G |
Adam28 |
ADAM metallopeptidase domain 28 |
|
ISO |
associated with breast cancer;DNA:hypermethylation: |
RGD |
PMID:25620615 |
RGD:153298970 |
NCBI chrNW_004936555:7,615,639...7,660,776
Ensembl chrNW_004936555:7,617,822...7,664,215
|
|
G |
Aicda |
activation induced cytidine deaminase |
|
ISO |
associated with stomach cancer;protein:increased expression:stomach (human) |
RGD |
PMID:21538122 |
RGD:127285638 |
NCBI chrNW_004936870:25,039...34,601
Ensembl chrNW_004936870:25,039...34,601
|
|
G |
Angptl4 |
angiopoietin like 4 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17130448 |
|
NCBI chrNW_004936588:5,188,866...5,194,924
Ensembl chrNW_004936588:5,188,850...5,194,931
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chrNW_004936503:9,124,314...9,142,372
Ensembl chrNW_004936503:9,124,264...9,142,413
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21401805 |
|
NCBI chrNW_004936524:1,963,427...1,969,977
Ensembl chrNW_004936524:1,963,247...1,969,998
|
|
G |
Arhgap5 |
Rho GTPase activating protein 5 |
|
ISO |
associated with nasopharynx carcinoma;mRNA, protein:increased expression: epithelium of nasopharynx |
RGD |
PMID:25961434 |
RGD:11056278 |
NCBI chrNW_004936494:6,562,092...6,624,015
Ensembl chrNW_004936494:6,562,069...6,623,175
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
|
ISO |
associated with colorectal cancer |
RGD |
PMID:32317519 |
RGD:126779580 |
NCBI chrNW_004936485:19,218,494...19,297,188
Ensembl chrNW_004936485:19,227,400...19,298,912
|
|
G |
Axl |
AXL receptor tyrosine kinase |
|
ISO |
associated Pancreatic Neoplasms |
RGD |
PMID:19252414 |
RGD:2325833 |
NCBI chrNW_004936661:3,658,140...3,687,290
Ensembl chrNW_004936661:3,657,831...3,687,816
|
|
G |
Bag1 |
BAG cochaperone 1 |
disease_progression |
ISO |
associated with Breast Neoplasms:protein:increased expression:breast |
RGD |
PMID:18430249 |
RGD:2292908 |
NCBI chrNW_004936524:1,793,001...1,804,145
Ensembl chrNW_004936524:1,791,119...1,804,151
|
|
G |
Bambi |
BMP and activin membrane bound inhibitor |
|
ISO |
associated with stomach cancer; protein:increased expression: : |
RGD |
PMID:24752577 |
RGD:14390158 |
NCBI chrNW_004936613:3,098,549...3,103,868
Ensembl chrNW_004936613:3,098,159...3,103,868
|
|
G |
Barhl2 |
BarH like homeobox 2 |
|
ISO |
associated with oral squamous cell carcinoma; mRNA:decreased expression:mouth mucosa |
RGD |
PMID:27542258 |
RGD:14390167 |
NCBI chrNW_004936537:8,129,213...8,134,744
Ensembl chrNW_004936537:8,129,207...8,135,237
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
|
ISO |
associated with Breast Neoplasms;protein:increased expression:lymph node |
RGD |
PMID:18217456 |
RGD:2293013 |
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
|
|
G |
Bik |
BCL2 interacting killer |
|
ISO |
associated with cholangiocarcinoma;DNA:CNV:: |
RGD |
PMID:16865775 |
RGD:14394820 |
|
|
G |
Birc5 |
baculoviral IAP repeat containing 5 |
disease_progression |
ISO |
associated with Breast Neoplasms associated with Cervix Neoplasms;mRNA:splice variant |
RGD |
PMID:17285241 PMID:17877643 |
RGD:2293098 RGD:2293103 |
NCBI chrNW_004936594:2,812,165...2,820,618
Ensembl chrNW_004936594:2,812,238...2,820,636
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29426936 |
|
NCBI chrNW_004936592:4,728,371...4,833,830
Ensembl chrNW_004936592:4,737,011...4,834,664
|
|
G |
Brd7 |
bromodomain containing 7 |
severity |
ISO |
protein:increased expression:lung: |
RGD |
PMID:22008115 |
RGD:9586442 |
NCBI chrNW_004936475:3,394,423...3,432,998
Ensembl chrNW_004936475:3,393,373...3,433,103
|
|
G |
Bsg |
basigin (Ok blood group) |
disease_progression |
ISO |
associated with Breast Neoplasms |
RGD |
PMID:16004819 |
RGD:2289055 |
NCBI chrNW_004936588:181,688...189,795
Ensembl chrNW_004936588:181,576...189,287
|
|
G |
Btk |
Bruton tyrosine kinase |
disease_progression |
ISO |
associated with lung adenocarcinoma;protein:increased expression:lung (human) |
RGD |
PMID:31200752 |
RGD:151347847 |
NCBI chrNW_004936813:429,400...467,481
Ensembl chrNW_004936813:429,224...463,441
|
|
G |
Ca9 |
carbonic anhydrase 9 |
|
ISO |
associated with Cervix Neoplasms |
RGD |
PMID:17233814 |
RGD:2293196 |
NCBI chrNW_004936524:3,672,393...3,678,630
Ensembl chrNW_004936524:3,672,541...3,678,433
|
|
G |
Cab39 |
calcium binding protein 39 |
|
ISO |
associated with pancreatic cancer;RNA:increased expression:pancreas |
RGD |
PMID:28197410 |
RGD:14398834 |
NCBI chrNW_004936525:5,955,252...6,002,917
Ensembl chrNW_004936525:5,954,978...6,032,644
|
|
G |
Casp9 |
caspase 9 |
|
ISO |
associated with Carcinoma, Non-Small-Cell Lung;DNA:SNP:exon:rs1052576 (human) |
RGD |
PMID:17285546 |
RGD:13434907 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
Cav1 |
caveolin 1 |
disease_progression |
ISO |
associated with Melanoma |
RGD |
PMID:22134245 |
RGD:8661767 |
NCBI chrNW_004936589:2,504,235...2,536,778
Ensembl chrNW_004936589:2,504,224...2,537,170
|
|
G |
Cbl |
Cbl proto-oncogene |
|
ISO |
associated with stomach carcinoma;protein:increased expression:stomach |
RGD |
PMID:31611438 |
RGD:126925223 |
NCBI chrNW_004936542:4,136,389...4,235,746
Ensembl chrNW_004936542:4,136,511...4,228,288
|
|
G |
Cblb |
Cbl proto-oncogene B |
|
ISO |
associated with stomach carcinoma; |
RGD |
PMID:20038312 |
RGD:150540338 |
NCBI chrNW_004936701:1,157,790...1,353,375
Ensembl chrNW_004936701:1,157,797...1,353,388
|
|
G |
Ccnd2 |
cyclin D2 |
|
ISO |
associated with colorectal cancer;protein:increased expression:colorectum |
RGD |
PMID:19508551 |
RGD:151665111 |
NCBI chrNW_004936606:4,474,801...4,496,158
Ensembl chrNW_004936606:4,474,749...4,496,810
|
|
G |
Ccne1 |
cyclin E1 |
|
ISO |
associated with Carcinoma, Transitional Cell;protein:decreased expression |
RGD |
PMID:16949911 |
RGD:2289266 |
NCBI chrNW_004936570:5,536,817...5,547,880
Ensembl chrNW_004936570:5,536,672...5,548,008
|
|
G |
Ccnh |
cyclin H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chrNW_004936469:5,933,163...5,952,190
Ensembl chrNW_004936469:5,935,131...5,952,460
|
|
G |
Cd274 |
CD274 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16530813 |
|
NCBI chrNW_004936539:132,870...145,288
Ensembl chrNW_004936539:132,868...143,602
|
|
G |
Cd40 |
CD40 molecule |
|
ISO |
associated with breast cancer;DNA:snps:5' utr, intron:c.-1T>C, c.51+914T>G (rs1883832, rs4810485) (human) |
RGD |
PMID:21912605 |
RGD:8547780 |
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
|
|
G |
Cd44 |
CD44 molecule (IN blood group) |
|
ISO |
associated with Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms;mRNA, protein:splice variant, increased expression:breast, large intestine, stomach |
RGD |
PMID:16425351 |
RGD:2289356 |
NCBI chrNW_004936533:2,949,026...3,033,166
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
associated with Breast Neoplasms associated with Cervix Neoplasms |
RGD |
PMID:17649807 PMID:18097581 |
RGD:2289498 RGD:2296046 |
NCBI chrNW_004936475:18,990,529...19,065,954
Ensembl chrNW_004936475:18,990,474...19,067,203
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
|
ISO |
associated with Eyelid Neoplasms; associated with Oral Squamous Cell Carcinoma; |
RGD |
PMID:15817070 PMID:19628749 |
RGD:8661799 RGD:8662374 |
NCBI chrNW_004936476:22,717,308...22,725,127
Ensembl chrNW_004936476:22,717,260...22,725,182
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
|
ISO |
associated with Breast Neoplasms associated with non-small cell lung carcinoma |
RGD |
PMID:12015771 PMID:28601655 |
RGD:13673921 RGD:2293607 |
NCBI chrNW_004936587:4,573,166...4,578,480
Ensembl chrNW_004936587:4,572,728...4,578,461
|
|
G |
Cldn1 |
claudin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33665778 |
|
NCBI chrNW_004936578:98,489...113,125
Ensembl chrNW_004936578:98,273...113,153
|
|
G |
Clptm1l |
CLPTM1 like |
|
ISO |
associated with esophagus squamous cell carcinoma; mRNA:increased expression:esophagus |
RGD |
PMID:25480402 |
RGD:150530497 |
NCBI chrNW_004936815:421,996...445,577
Ensembl chrNW_004936815:428,920...445,750
|
|
G |
Clu |
clusterin |
|
ISO |
associated with breast cancer;DNA:snp:promoter:g.27611345C>G (rs9331888) (human) |
RGD |
PMID:22037783 |
RGD:8963167 |
NCBI chrNW_004936675:499,745...513,515
Ensembl chrNW_004936675:499,199...513,836
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
associated with breast cancer;DNA:missense mutation:cds:p.V108/158M (human) |
RGD |
PMID:10755383 |
RGD:8662330 |
NCBI chrNW_004936619:3,847,059...3,883,866
Ensembl chrNW_004936619:3,876,299...3,882,747
|
|
G |
Crp |
C-reactive protein |
susceptibility |
ISO |
associated with Breast Neoplasm; DNA:polymorphism: :1846C>T(rs1205)(human) |
RGD |
PMID:24633920 |
RGD:9580226 |
NCBI chrNW_004936740:885,855...888,854
Ensembl chrNW_004936740:883,272...890,606
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
associated with Breast Neoplasms |
RGD |
PMID:14734466 |
RGD:2293711 |
NCBI chrNW_004936504:4,898,947...4,927,195
Ensembl chrNW_004936504:4,898,945...4,928,923
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
|
ISO |
associated with Prostatic Neoplasms |
RGD |
PMID:10611340 |
RGD:4891523 |
NCBI chrNW_004936631:484,356...489,643
Ensembl chrNW_004936631:484,356...489,643
|
|
G |
Ctnna1 |
catenin alpha 1 |
|
ISO |
associated with Breast Neoplasms |
RGD |
PMID:12047765 |
RGD:2289795 |
NCBI chrNW_004936531:7,865,907...8,036,020
Ensembl chrNW_004936531:7,865,820...8,037,935
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
associated with Breast Neoplasms;protein:decreased expression |
RGD |
PMID:17908479 |
RGD:2289813 |
NCBI chrNW_004936473:29,999,542...30,034,610
Ensembl chrNW_004936473:29,999,562...30,038,293
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
disease_progression |
ISO |
associated with stomach cancer;mRNA:increased expression:stomach (human) |
RGD |
PMID:21633638 |
RGD:152023624 |
NCBI chrNW_004936617:4,224,131...4,239,080
Ensembl chrNW_004936617:4,224,131...4,238,796
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
ISO |
associated with nasopharynx carcinoma; protein:increased expression:lymph node (human) |
RGD |
PMID:16000558 |
RGD:151893515 |
NCBI chrNW_004936469:39,794,613...39,798,448
Ensembl chrNW_004936469:39,794,584...39,798,459
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
severity |
ISO |
mRNA, protein:increased expression:mouth (human) mRNA:increased expression:kidney, lymph nodes (human) |
RGD |
PMID:27020590 PMID:31253192 |
RGD:151347620 RGD:151347863 |
NCBI chrNW_004936837:523,227...538,799
Ensembl chrNW_004936837:523,266...538,833
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
disease_progression |
ISO |
associated with oral squamous cell carcinoma |
RGD |
PMID:29945346 |
RGD:150429700 |
NCBI chrNW_004936831:799,948...946,139
Ensembl chrNW_004936831:865,965...946,139
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
|
ISO |
associated with Carcinoma, Pancreatic Ductal; |
RGD |
PMID:22919364 |
RGD:9589121 |
NCBI chrNW_004936485:19,547,836...19,570,716
|
|
G |
Ebag9 |
estrogen receptor binding site associated antigen 9 |
|
ISO |
associated with Breast Neoplasms;protein:increased expression:breast associated with Prostatic Neoplasm;protein:increased expression:prostate gland, lymph node |
RGD |
PMID:12054692 PMID:12845666 PMID:17187007 |
RGD:2289847 RGD:2289856 RGD:2298489 |
NCBI chrNW_004936470:35,449,920...35,473,635
Ensembl chrNW_004936470:35,450,292...35,473,110
|
|
G |
Egfr |
epidermal growth factor receptor |
treatment |
ISO |
associated with Squamous Cell Carcinoma of the Tongue |
RGD |
PMID:19380367 |
RGD:8551769 |
NCBI chrNW_004936678:365,005...560,546
Ensembl chrNW_004936678:365,834...436,528
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
|
ISO |
associated with Melanoma; associated with Esophageal Squamous Cell Carcinoma; |
RGD |
PMID:24658378 PMID:24805087 |
RGD:9590069 RGD:9590071 |
NCBI chrNW_004936727:1,648,451...1,663,294
Ensembl chrNW_004936727:1,648,448...1,663,455
|
|
G |
Epha2 |
EPH receptor A2 |
|
ISO |
protein:increased expression:esophagus (human) |
RGD |
PMID:33833989 |
RGD:153344568 |
NCBI chrNW_004936474:3,648,395...3,673,856
Ensembl chrNW_004936474:3,648,550...3,673,861
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
disease_progression |
ISO |
associated with Carcinoma, Transitional Cell;protein:increased expression:urinary bladder associated with lung adenocarcinoma; protein:increased expression:lung (human) CTD Direct Evidence: marker/mechanism associated with Breast Neoplasms;DNA, protein:polymorphism, increased expression:serum:p.I655V |
RGD CTD |
PMID:18097576 PMID:18237248 PMID:21532492 PMID:21966491 |
RGD:153344600 RGD:2289925 RGD:2289926 |
NCBI chrNW_004936490:14,887,062...14,910,038
Ensembl chrNW_004936490:14,887,043...14,909,956
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
|
ISO |
associated with Prostatic Neoplasms;protein:increased expression, altered localization:lymph node, nucleus associated with head and neck squamous cell carcinoma |
RGD |
PMID:17634423 PMID:20604875 |
RGD:126790467 RGD:2289944 |
NCBI chrNW_004936646:497,783...515,247
Ensembl chrNW_004936646:498,749...513,297
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
severity disease_progression |
ISO |
associated with oral squamous cell carcinoma associated with colorectal adenocarcinoma associated with lung non-small cell carcinoma |
RGD |
PMID:16507107 PMID:21324275 PMID:27444519 |
RGD:126781762 RGD:126781766 RGD:126790471 |
NCBI chrNW_004936586:4,065,767...5,100,690
Ensembl chrNW_004936586:4,066,498...5,100,035
|
|
G |
Fas |
Fas cell surface death receptor |
susceptibility |
ISO |
associated with Cervix Neoplasms;DNA:polymorphism:promoter:-1377G>A |
RGD |
PMID:18068525 |
RGD:2298509 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
|
ISO |
associated with Cervix Neoplasms;mRNA:increased expression:lymph node |
RGD |
PMID:17242701 |
RGD:2290286 |
NCBI chrNW_004936504:11,590,687...11,684,410
Ensembl chrNW_004936504:11,590,637...11,685,194
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
associated with breast cancer;DNA:snp:intron:c.109+7033T>A (rs1219648) (human) |
RGD |
PMID:20640597 |
RGD:7394846 |
NCBI chrNW_004936486:10,506,680...10,606,272
Ensembl chrNW_004936486:10,507,097...10,602,019
|
|
G |
Flt3 |
fms related receptor tyrosine kinase 3 |
disease_progression |
ISO |
associated with Prostatic Neoplasms |
RGD |
PMID:14566827 |
RGD:2302210 |
NCBI chrNW_004936472:23,169,967...23,239,178
Ensembl chrNW_004936472:23,170,470...23,256,904
|
|
G |
Foxa1 |
forkhead box A1 |
|
ISO |
associated with lung non-small cell carcinoma; mRNA:increased expression: : |
RGD |
PMID:29115441 |
RGD:151665751 |
NCBI chrNW_004936494:11,529,546...11,535,224
Ensembl chrNW_004936494:11,529,546...11,535,224
|
|
G |
Foxp1 |
forkhead box P1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25485836 |
|
NCBI chrNW_004936603:2,631,781...3,146,104
Ensembl chrNW_004936603:2,632,274...2,830,324
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
ISO |
associated with stomach carcinoma; DNA:hypermethylation:promoter |
RGD |
PMID:23071548 |
RGD:151665353 |
NCBI chrNW_004936647:3,904,787...3,914,223
Ensembl chrNW_004936647:3,906,113...3,913,498
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chrNW_004936651:2,756,559...3,401,806
Ensembl chrNW_004936651:2,762,380...3,401,808
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
associated with Adenocarcinoma, Colon |
RGD |
PMID:20616616 |
RGD:10402080 |
NCBI chrNW_004936472:25,236,728...25,246,585
Ensembl chrNW_004936472:25,236,728...25,246,580
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
associated with Breast Neoplasms |
RGD |
PMID:21590495 |
RGD:8547712 |
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
|
|
G |
Ier2 |
immediate early response 2 |
|
ISO |
|
RGD |
PMID:22120713 |
RGD:153323322 |
NCBI chrNW_004936659:2,176,962...2,179,900
Ensembl chrNW_004936659:2,178,312...2,178,983
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
associated with Melanoma, Cutaneous Malignant;mRNA:increased expression:lymph node |
RGD |
PMID:17545514 |
RGD:8549587 |
NCBI chrNW_004936647:2,529,933...2,532,503
Ensembl chrNW_004936647:2,530,491...2,532,373
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
associated with Breast Neoplasms;protein:increased expression:serum |
RGD |
PMID:12902898 |
RGD:8655867 |
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
|
|
G |
Ing4 |
inhibitor of growth family member 4 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27806345 |
|
NCBI chrNW_004936709:1,140,485...1,147,982
Ensembl chrNW_004936709:1,140,345...1,149,843
|
|
G |
Iqsec1 |
IQ motif and Sec7 domain ArfGEF 1 |
disease_progression |
ISO |
associated with lung adenocarcinoma; protein:increased expression:lung (human) |
RGD |
PMID:21966491 |
RGD:153344600 |
NCBI chrNW_004936898:318,564...425,785
Ensembl chrNW_004936898:337,400...425,859
|
|
G |
Itgb1 |
integrin subunit beta 1 |
|
ISO |
associated with non-small cell lung carcinoma, |
RGD |
PMID:28537888 |
RGD:13792830 |
NCBI chrNW_004936574:1,465,981...1,495,717
Ensembl chrNW_004936574:1,465,897...1,495,762
|
|
G |
Kcnj12 |
potassium inwardly rectifying channel subfamily J member 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34755307 |
|
NCBI chrNW_004936741:266,311...303,947
|
|
G |
Kdr |
kinase insert domain receptor |
treatment |
ISO |
associated with Squamous Cell Carcinoma of the Tongue |
RGD |
PMID:19380367 |
RGD:8551769 |
NCBI chrNW_004936482:17,537,697...17,581,320
Ensembl chrNW_004936482:17,538,864...17,581,002
|
|
G |
Kiss1 |
KiSS-1 metastasis suppressor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21383688 |
|
NCBI chrNW_004936567:584,443...595,045
Ensembl chrNW_004936567:584,443...586,837
|
|
G |
Klf7 |
KLF transcription factor 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:37734194 |
|
NCBI chrNW_004936631:3,327,555...3,412,206
Ensembl chrNW_004936631:3,329,681...3,412,252
|
|
G |
Kmt2d |
lysine methyltransferase 2D |
|
ISO |
associated with stomach cancer |
RGD |
PMID:30177394 |
RGD:150521710 |
NCBI chrNW_004936512:6,819,240...6,860,852
Ensembl chrNW_004936512:6,822,057...6,854,451
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
|
ISO |
associated with lung squamous cell carcinoma; |
RGD |
PMID:23124251 |
RGD:13793371 |
NCBI chrNW_004936481:6,588,797...6,647,167
Ensembl chrNW_004936481:6,588,865...6,647,188
|
|
G |
LOC101964702 |
adhesion G protein-coupled receptor B1 |
disease_progression |
ISO |
associated with stomach cancer; |
RGD |
PMID:11172604 |
RGD:13831357 |
NCBI chrNW_004936470:9,247,749...9,313,230
Ensembl chrNW_004936470:9,248,319...9,313,230
|
|
G |
Lrrc59 |
leucine rich repeat containing 59 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chrNW_004936490:11,296,590...11,308,379
Ensembl chrNW_004936490:11,296,530...11,310,946
|
|
G |
Macir |
macrophage immunometabolism regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chrNW_004936523:1,273,812...1,292,837
Ensembl chrNW_004936523:1,275,214...1,292,854
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29426936 |
|
NCBI chrNW_004936589:2,280,803...2,390,179
Ensembl chrNW_004936589:2,280,799...2,390,179
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
disease_progression |
ISO |
associated with Carcinoma, Ductal, Breast associated with Tongue Neoplasms |
RGD |
PMID:23107277 PMID:23280016 |
RGD:8547824 RGD:8655998 |
NCBI chrNW_004936475:7,801,356...7,825,831
Ensembl chrNW_004936475:7,801,277...7,825,851
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
disease_progression |
ISO |
associated with Tongue Neoplasms associated with Carcinoma, Non-Small-Cell Lung;protein:increased expression:serum associated with Endometrial Neoplasms;protein:increased expression:endometrium |
RGD |
PMID:12487935 PMID:20704821 PMID:23107277 |
RGD:2298523 RGD:5129215 RGD:8547824 |
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
|
|
G |
Msh2 |
mutS homolog 2 |
|
ISO |
associated with laryngeal squamous cell carcinoma |
RGD |
PMID:24459922 |
RGD:126848797 |
NCBI chrNW_004936508:4,943,987...5,013,356
Ensembl chrNW_004936508:4,944,007...5,013,356
|
|
G |
Mta1 |
metastasis associated 1 |
|
ISO |
associated with Carcinoma, Non-Small-Cell Lung;mRNA:increased expression:lung |
RGD |
PMID:11804687 |
RGD:9588220 |
NCBI chrNW_004936621:117,785...140,917
Ensembl chrNW_004936621:117,785...140,926
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chrNW_004936474:158,376...282,310
Ensembl chrNW_004936474:157,590...282,342
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
associated with Gallbladder Neoplasms;protein:altered localization:gallbladder associated with Esophageal Neoplasms associated with Common Bile Duct Neoplasms associated with Carcinoma, Renal Cell; |
RGD |
PMID:10390012 PMID:11295067 PMID:16222735 PMID:21339746 |
RGD:2324649 RGD:2324860 RGD:7245968 RGD:7349383 |
NCBI chrNW_004936580:4,691,870...4,694,092
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
associated with chloangiocarcinoma;protein:increased expression:bile duct |
RGD |
PMID:16842244 |
RGD:2325168 |
NCBI chrNW_004936816:129,926...159,396
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:10086383 |
RGD:2326067 |
NCBI chrNW_004936612:1,262,557...1,556,281
Ensembl chrNW_004936612:1,262,544...1,556,016
|
|
G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
ISO |
associated with Cervix Neoplasms; associated with Endometrial Neoplasms |
RGD |
PMID:8855975 |
RGD:2299062 |
NCBI chrNW_004936490:10,634,788...10,640,182
Ensembl chrNW_004936490:10,633,454...10,649,914
|
|
G |
Nos3 |
nitric oxide synthase 3 |
susceptibility |
ISO |
associated with Breast Neoplasms;DNA:polymorphisms:promoter, exon:-786T>C,p.E298D (human) |
RGD |
PMID:17262178 |
RGD:2292070 |
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
associated with breast cancer;DNA:missense mutation:cds:p.S326C (rs1052133) (human) |
RGD |
PMID:18977234 |
RGD:8657156 |
NCBI chrNW_004936602:3,411,106...3,418,826
Ensembl chrNW_004936602:3,413,282...3,418,831
|
|
G |
Pagr1 |
PAXIP1 associated glutamate rich protein 1 |
disease_progression |
ISO |
protein:decreased expression:esophagus (human) |
RGD |
PMID:33833989 |
RGD:153344568 |
NCBI chrNW_004936501:12,657,092...12,660,106
Ensembl chrNW_004936501:12,656,435...12,660,067
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
|
ISO |
associated with Breast Neoplasms;mRNA:increased expression:breast |
RGD |
PMID:8619189 |
RGD:2292155 |
NCBI chrNW_004936754:808,894...828,554
Ensembl chrNW_004936754:808,213...828,613
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
associated with Breast Neoplasms;mRNA:increased expression:lymph node |
RGD |
PMID:17674348 |
RGD:2292173 |
NCBI chrNW_004936492:2,353,840...2,368,573
Ensembl chrNW_004936492:2,353,841...2,368,573
|
|
G |
Pdpk1 |
3-phosphoinositide dependent protein kinase 1 |
|
ISO |
associated with non-small cell lung carcinoma;mRNA:increased expression:blood serum |
RGD |
PMID:25064732 |
RGD:13503320 |
NCBI chrNW_004936694:1,444,819...1,487,628
Ensembl chrNW_004936694:1,444,880...1,488,265 Ensembl chrNW_004936694:1,444,880...1,488,265
|
|
G |
Pdpn |
podoplanin |
|
ISO |
associated with Breast Neoplasms associated with Cervix Neoplasms |
RGD |
PMID:16528371 PMID:18165897 |
RGD:2292231 RGD:2292237 |
NCBI chrNW_004936474:1,751,159...1,779,011
Ensembl chrNW_004936474:1,750,944...1,781,156
|
|
G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
|
ISO |
associated with Breast Neoplasms associated with Cervix Neoplasms |
RGD |
PMID:16243812 PMID:18191186 |
RGD:2302867 RGD:2302868 |
NCBI chrNW_004936668:2,316,661...2,323,015
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
|
ISO |
associated with Colorectal Neoplasms |
RGD |
PMID:25550888 |
RGD:13432030 |
NCBI chrNW_004936566:3,924,013...3,951,052
Ensembl chrNW_004936566:3,923,934...3,951,073
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
|
ISO |
associated with Colorectal Neoplasms |
RGD |
PMID:25550888 |
RGD:13432030 |
NCBI chrNW_004936540:907,118...1,041,814
Ensembl chrNW_004936540:907,112...1,041,848
|
|
G |
Pip5k1a |
phosphatidylinositol-4-phosphate 5-kinase type 1 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34755307 |
|
NCBI chrNW_004936580:1,399,492...1,448,398
Ensembl chrNW_004936580:1,399,954...1,446,769
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
|
ISO |
associated with Seminoma; associated with Carcinoma, Embryonal |
RGD |
PMID:15386301 |
RGD:2292442 |
NCBI chrNW_004936837:827,568...838,933
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
associated with Cholangiocarcinoma;protein:increased expression:bile duct epithelium |
RGD |
PMID:20021832 |
RGD:2317459 |
NCBI chrNW_004936602:1,230,907...1,368,588
Ensembl chrNW_004936602:1,230,907...1,304,743
|
|
G |
Prex1 |
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 |
|
ISO |
associated with Prostatic Neoplasms |
RGD |
PMID:19305425 |
RGD:2314605 |
NCBI chrNW_004936514:5,291,473...5,443,999
Ensembl chrNW_004936514:5,368,629...5,444,003
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
associated with Prostatic Neoplasms;protein:decreased expression:prostate associated with Breast Neoplasms |
RGD |
PMID:17163422 PMID:17919877 |
RGD:2292499 RGD:2292507 |
NCBI chrNW_004936735:1,252,414...1,338,318
Ensembl chrNW_004936735:1,252,414...1,338,323
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
associated with Biliary Tract Neoplasms associated with carcinoma, non-small-cell lung; DNA:SNP: :929G>C(human) associated with Breast Neoplasms |
RGD |
PMID:18159174 PMID:18353210 PMID:20016751 |
RGD:2300128 RGD:2317165 RGD:5135471 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
|
ISO |
associated with lung squamous cell carcinoma; protein:increased tyrosine phosphorylation:lymph node |
RGD |
PMID:23906871 |
RGD:152176664 |
NCBI chrNW_004936470:10,379,855...10,578,531
Ensembl chrNW_004936470:10,379,872...10,578,543
|
|
G |
Ptpn13 |
protein tyrosine phosphatase non-receptor type 13 |
|
ISO |
associated with lung squamous cell carcinoma; protein:decreased expression:lymph node |
RGD |
PMID:23906871 |
RGD:152176664 |
NCBI chrNW_004936920:313,762...510,334
Ensembl chrNW_004936920:313,814...510,001
|
|
G |
Ramp2 |
receptor activity modifying protein 2 |
disease_progression |
ISO |
associated with colorectal cancer; protein:increased expression:lymph node (human) |
RGD |
PMID:23634287 |
RGD:151708733 |
NCBI chrNW_004936490:17,479,899...17,481,788
Ensembl chrNW_004936490:17,479,650...17,482,716
|
|
G |
Ramp3 |
receptor activity modifying protein 3 |
|
ISO |
associated with colorectal cancer; protein:increased expression:lymph node (human) |
RGD |
PMID:23634287 |
RGD:151708733 |
NCBI chrNW_004936478:19,977,618...20,001,366
Ensembl chrNW_004936478:19,977,539...20,004,838
|
|
G |
Rassf2 |
Ras association domain family member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17013896 |
|
NCBI chrNW_004936485:13,997,688...14,042,712
Ensembl chrNW_004936485:13,997,652...14,042,578
|
|
G |
Rbm10 |
RNA binding motif protein 10 |
|
ISO |
associated with lung adenocarcinoma;DNA:missense mutation:exon:p.R241C (c.763C>T) (human) |
RGD |
PMID:30405763 |
RGD:151356993 |
NCBI chrNW_004936502:12,923,890...12,952,179
Ensembl chrNW_004936502:12,925,910...12,955,470
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
associated with Prostatic Neoplasms;protein:altered localization:nucleus, prostate gland |
RGD |
PMID:17020979 |
RGD:2298757 |
NCBI chrNW_004936599:3,800,142...3,810,583
Ensembl chrNW_004936599:3,801,636...3,809,813
|
|
G |
Ret |
ret proto-oncogene |
|
ISO |
associated with Pancreatic Neoplasms |
RGD |
PMID:18652760 |
RGD:2324925 |
NCBI chrNW_004936617:2,927,185...2,980,594
Ensembl chrNW_004936617:2,927,155...2,980,602
|
|
G |
Rhoa |
ras homolog family member A |
|
ISO |
associated with Bladder Neoplasms;protein:increased expression:lymph node associated with colorectal cancer |
RGD |
PMID:12855641 PMID:17597401 |
RGD:13432052 RGD:2298872 |
NCBI chrNW_004936529:1,000,050...1,045,655
Ensembl chrNW_004936529:999,935...1,045,681
|
|
G |
Rictor |
RPTOR independent companion of MTOR complex 2 |
|
ISO |
associated with breast ductal carcinoma; protein:increased expression:breast tumor, lymph node (human) |
RGD |
PMID:20978191 |
RGD:152995469 |
NCBI chrNW_004936518:3,198,312...3,314,393
Ensembl chrNW_004936518:3,198,337...3,310,000
|
|
G |
Sfn |
stratifin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381893 |
|
NCBI chrNW_004936474:11,274,927...11,279,427
Ensembl chrNW_004936474:11,246,534...11,279,433
|
|
G |
Skp2 |
S-phase kinase associated protein 2 |
|
ISO |
associated with Endometrial Neoplasms;protein:increased expression:endometrium |
RGD |
PMID:16080017 |
RGD:2315043 |
NCBI chrNW_004936518:5,635,856...5,664,057
Ensembl chrNW_004936518:5,637,331...5,664,778
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
severity |
ISO |
associated with gastric adenocarcinoma;protein:increased expression: : associated with stomach carcinoma |
RGD |
PMID:21501294 PMID:25908107 |
RGD:11052781 RGD:151361203 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
associated with Breast Neoplasms |
RGD |
PMID:11809701 |
RGD:2300007 |
NCBI chrNW_004936497:12,242,869...12,278,012
Ensembl chrNW_004936497:12,249,140...12,278,123
|
|
G |
Smo |
smoothened, frizzled class receptor |
|
ISO |
associated with colorectal cancer |
RGD |
PMID:30784110 |
RGD:150520177 |
NCBI chrNW_004936579:5,893,064...5,917,021
Ensembl chrNW_004936579:5,892,542...5,917,281
|
|
G |
Sncg |
synuclein gamma |
|
ISO |
|
RGD |
PMID:15221989 |
RGD:6478801 |
NCBI chrNW_004936804:16,869...21,684
Ensembl chrNW_004936804:16,614...21,969
|
|
G |
Socs2 |
suppressor of cytokine signaling 2 |
|
ISO |
associated with Prostatic Neoplasms |
RGD |
PMID:16707422 |
RGD:2298925 |
NCBI chrNW_004936507:10,013,982...10,015,480
Ensembl chrNW_004936507:10,012,101...10,014,456
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
ISO |
associated with Breast Neoplasms |
RGD |
PMID:18097573 |
RGD:2298901 |
NCBI chrNW_004936594:2,932,297...2,935,358
Ensembl chrNW_004936594:2,933,747...2,934,451
|
|
G |
Sod2 |
superoxide dismutase 2 |
disease_progression |
ISO |
associated with tongue neoplasms; CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:10853026 PMID:19381893 PMID:20618948 |
RGD:8547519 |
NCBI chrNW_004936489:11,178,338...11,191,601
Ensembl chrNW_004936489:11,178,015...11,191,781
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
disease_progression |
ISO |
associated with Breast Neoplasms |
RGD |
PMID:24382260 |
RGD:8661670 |
NCBI chrNW_004936566:1,630,698...1,632,607
Ensembl chrNW_004936566:1,631,822...1,632,613
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
|
ISO |
associated with colon adenocarcinoma, |
RGD |
PMID:21282564 |
RGD:150520218 |
NCBI chrNW_004936561:3,826,802...3,844,406
Ensembl chrNW_004936561:3,825,787...3,844,483
|
|
G |
St14 |
ST14 transmembrane serine protease matriptase |
|
ISO |
associated with Endometrial Neoplasms |
RGD |
PMID:19443387 |
RGD:2315087 |
NCBI chrNW_004936572:2,137,820...2,182,674
Ensembl chrNW_004936572:2,137,332...2,182,742
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549414 |
|
NCBI chrNW_004936490:17,119,189...17,178,402
Ensembl chrNW_004936490:17,117,290...17,178,402
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
ISO |
associated with Breast Neoplasms;protein:decreased expression |
RGD |
PMID:12114407 |
RGD:2291948 |
NCBI chrNW_004936588:579,816...601,033
Ensembl chrNW_004936588:579,816...603,654
|
|
G |
Tert |
telomerase reverse transcriptase |
disease_progression |
ISO |
associated with lung non-small cell carcinoma; |
RGD |
PMID:11679180 |
RGD:152977755 |
NCBI chrNW_004936815:468,987...492,666
Ensembl chrNW_004936815:469,020...491,697
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
associated with Endometrial Neoplasms;protein:increased expression:endometrium |
RGD |
PMID:12487935 |
RGD:2298523 |
NCBI chrNW_004936502:13,345,936...13,350,170
Ensembl chrNW_004936502:13,345,832...13,350,248
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
associated with Breast Neoplasms;mRNA:increased expression:breast |
RGD |
PMID:12828172 |
RGD:2290437 |
NCBI chrNW_004936492:6,996,627...7,046,137
Ensembl chrNW_004936492:6,996,613...7,046,190
|
|
G |
Timp4 |
TIMP metallopeptidase inhibitor 4 |
|
ISO |
associated with Breast Neoplasms;mRNA:increased expression:breast |
RGD |
PMID:12828172 |
RGD:2290437 |
NCBI chrNW_004936602:1,488,993...1,496,108
Ensembl chrNW_004936602:1,489,545...1,495,478
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
associated with Carcinoma, Ductal, Breast; |
RGD |
PMID:23338716 |
RGD:7794684 |
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
associated with Carcinoma, Squamous Cell; associated with Breast Neoplasms;DNA:missense mutation, duplication:cds, intron:p.R72P associated with Penile Neoplasms |
RGD |
PMID:18059331 PMID:18230179 PMID:18268397 |
RGD:2290533 RGD:2290534 RGD:8547790 |
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
|
|
G |
Tp53bp1 |
tumor protein p53 binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chrNW_004936471:6,589,395...6,668,242
Ensembl chrNW_004936471:6,589,564...6,668,305
|
|
G |
Trmt11 |
tRNA methyltransferase 11 homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chrNW_004936639:3,442,026...3,494,303
Ensembl chrNW_004936639:3,440,703...3,494,362
|
|
G |
Tsc2 |
TSC complex subunit 2 |
|
ISO |
associated with Breast Neoplasms |
RGD |
PMID:15951164 |
RGD:11568707 |
NCBI chrNW_004936694:1,958,152...1,993,373
Ensembl chrNW_004936694:1,958,154...1,993,363
|
|
G |
Tshr |
thyroid stimulating hormone receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9062474 |
|
NCBI chrNW_004936488:9,428,053...9,560,856
Ensembl chrNW_004936488:9,427,962...9,560,685
|
|
G |
Ttr |
transthyretin |
|
ISO |
associated with colorectal cancer;protein:decreased expresion:blood serum (human) |
RGD |
PMID:21074777 |
RGD:151665155 |
NCBI chrNW_004936682:1,628,489...1,635,495
Ensembl chrNW_004936682:1,628,341...1,635,566
|
|
G |
Tymp |
thymidine phosphorylase |
|
ISO |
associated with Breast Neoplasms associated with Cholangiocarcinoma |
RGD |
PMID:10685502 PMID:11927969 |
RGD:2293725 RGD:2325027 |
NCBI chrNW_004936629:315,609...320,356
Ensembl chrNW_004936629:315,610...319,076
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
associated with Breast neoplasms; associated with Cervix Neoplasms |
RGD |
PMID:17597103 PMID:19783962 |
RGD:2315454 RGD:7421574 |
NCBI chrNW_004936476:16,245,134...16,261,180
Ensembl chrNW_004936476:16,247,100...16,260,673
|
|
G |
Vegfc |
vascular endothelial growth factor C |
exacerbates disease_progression |
ISO |
associated with Lymphatic Metastasis; associated with pancreatic adenocarcinoma;protein:increased expression:pancreas (human) associated with thyroid diseases;mRNA:increased expression:thyroid gland: associated with Prostatic Neoplasms associated with Breast Neoplasms associated with Carcinoma, Transitional Cell;protein:increased expression:urinary bladder associated with Cervix Neoplasms |
RGD |
PMID:12203051 PMID:15289890 PMID:17034609 PMID:18061373 PMID:19589137 PMID:19608016 PMID:19923084 More...
|
RGD:155630642 RGD:2315469 RGD:2315474 RGD:2315475 RGD:2315484 RGD:7483611 RGD:7488946 |
NCBI chrNW_004936516:7,217,543...7,332,531
Ensembl chrNW_004936516:7,217,543...7,332,559
|
|
G |
Vegfd |
vascular endothelial growth factor D |
|
ISO |
associated with Cervix Neoplasms associated with Breast Neoplasms |
RGD |
PMID:17951197 PMID:19589137 |
RGD:2315475 RGD:2315480 |
NCBI chrNW_004936470:4,761,827...4,794,751
Ensembl chrNW_004936470:4,762,332...4,793,938
|
|
G |
Wrap53 |
WD repeat containing antisense to TP53 |
|
ISO |
associated with lung non-small cell carcinoma; associated with esophagus squamous cell carcinoma; |
RGD |
PMID:24626331 PMID:31281482 |
RGD:21081513 RGD:21081532 |
NCBI chrNW_004936595:936,184...952,784
Ensembl chrNW_004936595:936,487...952,791
|
|